Cytotoxic granule secretion by lymphocytes and its link to immune homeostasis

F1000Research

Volumn 4, Issue , 2015, Pages

  de Saint Basile, Geneviève ^a,b,c   Sepulveda, Fernando E ^a,b   Maschalidi, Sophia ^a,b   Fischer, Alain ^a,b,d,e  

^a INSERM   (France)

^b Hôpital Necker Enfants Malades   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

Cytotoxic; Haemophagocytic lymphohistiocytosis; Natural killer lymphocytes

Indexed keywords

EID: 84988449686     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.6754.1     Document Type: Review

References (76)

1. Stinchcombe JC Bossi G Booth S: The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity. 2001;15(5):751-61. 11728337 10.1016/S1074-7613(01)00234-5
2. Stepp SE Dufourcq-Lagelouse R Le Deist F: Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957-9. 10583959 10.1126/science.286.5446.1957
3. Kägi D Seiler P Pavlovic J: The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol. 1995;25(12):3256-62. 8566009 10.1002/eji.1830251209
4. Jordan MB Hildeman D Kappler J: An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8 + T cells and interferon gamma are essential for the disorder. Blood. 2004;104(3):735-43. 15069016 10.1182/blood-2003-10-3413
5. Pachlopnik Schmid J Côte M Ménager MM: Inherited defects in lymphocyte cytotoxic activity. Immunol Rev. 2010;235(1):10-23. 20536552
6. Janka GE: Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233-46. 22248322 10.1146/annurev-med-041610-134208
7. Janka GE Lehmberg K: Hemophagocytic syndromes--an update. Blood Rev. 2014;28(4):135-42. 24792320 10.1016/j.blre.2014.03.002
8. de Saint Basile G Ménasché G Fischer A: Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol. 2010;10(8):568-79. 20634814 10.1038/nri2803
9. Behrens EM Cron RQ: Kill or be killed. J Immunol. 2015;194(11):5041-3. 25980027 10.4049/jimmunol.1500774
10. Jessen B Kögl T Sepulveda FE: Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice. Front Immunol. 2013;4:448. 24379813 10.3389/fimmu.2013.00448 3864253
11. Sepulveda FE Maschalidi S Vosshenrich CAJ: A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood. 2015;125(9):1427-34. 25525117 10.1182/blood-2014-09-602946
12. Orange JS: Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol. 2008;8(9):713-25. 19172692 10.1038/nri2381 2772177
13. Ritter AT Asano Y Stinchcombe JC: Actin depletion initiates events leading to granule secretion at the immunological synapse. Immunity. 2015;42(5):864-76. 25992860 10.1016/j.immuni.2015.04.013 4448150
14. Browne KA Johnstone RW Jans DA: Filamin (280-kDa actin-binding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis. J Biol Chem. 2000;275(50):39262-6. 11050075 10.1074/jbc.C000622200
15. Rak GD Mace EM Banerjee PP: Natural killer cell lytic granule secretion occurs through a pervasive actin network at the immune synapse. PLoS Biol. 2011;9(9):e1001151. 21931536 10.1371/journal.pbio.1001151 3172191
16. Dustin ML Long EO: Cytotoxic immunological synapses. Immunol Rev. 2010;235(1):24-34. 20536553 10.1111/j.0105-2896.2010.00904.x 2950621
17. Stinchcombe JC Majorovits E Bossi G: Centrosome polarization delivers secretory granules to the immunological synapse. Nature. 2006;443(7110):462-5. 17006514 10.1038/nature05071
18. Voskoboinik I Whisstock JC Trapani JA: Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15(6):388-400. 25998963 10.1038/nri3839
19. Law RHP Lukoyanova N Voskoboinik I: The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature. 2010;468(7322):447-51. 21037563 10.1038/nature09518
20. Baran K Dunstone M Chia J: The molecular basis for perforin oligomerization and transmembrane pore assembly. Immunity. 2009;30(5):684-95. 19446473 10.1016/j.immuni.2009.03.016
21. Lopez JA Susanto O Jenkins MR: Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood. 2013;121(14):2659-68. 23377437 10.1182/blood-2012-07-446146
22. Lopez JA Jenkins MR Rudd-Schmidt JA: Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapse. J Immunol. 2013;191(5):2328-34. 23885110 10.4049/jimmunol.1301205
23. Keefe D Shi L Feske S: Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. Immunity. 2005;23(3):249-62. 16169498 10.1016/j.immuni.2005.08.001
24. Miaczynska M Zerial M: Mosaic organization of the endocytic pathway. Exp Cell Res. 2002;272(1):8-14. 11740860 10.1006/excr.2001.5401
25. Thiery J Keefe D Boulant S: Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells. Nat Immunol. 2011;12(8):770-7. 21685908 10.1038/ni.2050 3140544
26. Feldmann J Callebaut I Raposo G: Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115(4):461-73. 14622600 10.1016/S0092-8674(03)00855-9
27. Zur Stadt U Schmidt S Kasper B: Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14(6):827-34. 15703195 10.1093/hmg/ddi076
28. Zur Stadt U Rohr J Seifert W: Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85(4):482-92. 19804848 10.1016/j.ajhg.2009.09.005 2756548
29. Côte M Ménager MM Burgess A: Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119(12):3765-73. 19884660 10.1172/JCI40732 2786810
30. Ménasché G Pastural E Feldmann J: Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet. 2000;25(2):173-6. 10835631 10.1038/76024
31. Nagle DL Karim MA Woolf EA: Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet. 1996;14(3):307-11. 8896560 10.1038/ng1196-307
32. Sepulveda FE Burgess A Heiligenstein X: LYST controls the biogenesis of the endosomal compartment required for secretory lysosome function. Traffic. 2015;16(2):191-203. 25425525 10.1111/tra.12244
33. Elstak ED Neeft M Nehme NT: The munc13-4-rab27 complex is specifically required for tethering secretory lysosomes at the plasma membrane. Blood. 2011;118(6):1570-8. 21693760 10.1182/blood-2011-02-339523
34. Boswell KL James DJ Esquibel JM: Munc13-4 reconstitutes calcium-dependent SNARE-mediated membrane fusion. J Cell Biol. 2012;197(2):301-12. 22508512 10.1083/jcb.201109132 3328385
35. Kurowska M Goudin N Nehme NT: Terminal transport of lytic granules to the immune synapse is mediated by the kinesin-1/Slp3/Rab27a complex. Blood. 2012;119(17):3879-89. 22308290 10.1182/blood-2011-09-382556 3824283
36. Holt O Kanno E Bossi G: Slp1 and Slp2-a localize to the plasma membrane of CTL and contribute to secretion from the immunological synapse. Traffic. 2008;9(4):446-57. 18266782 10.1111/j.1600-0854.2008.00714.x 2329822
37. Ménasché G Ménager MM Lefebvre JM: A newly identified isoform of Slp2a associates with Rab27a in cytotoxic T cells and participates to cytotoxic granule secretion. Blood. 2008;112(13):5052-62. 18812475 10.1182/blood-2008-02-141069
38. Stinchcombe JC Salio M Cerundolo V: Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems. BMC Biol. 2011;9:45. 21711522 10.1186/1741-7007-9-45 3149597
39. Bertrand F Müller S Roh KH: An initial and rapid step of lytic granule secretion precedes microtubule organizing center polarization at the cytotoxic T lymphocyte/target cell synapse. Proc Natl Acad Sci U S A. 2013;110(15):6073-8. 23536289 10.1073/pnas.1218640110 3625254
40. Choi PJ Mitchison TJ: Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells. Proc Natl Acad Sci U S A. 2013;110(16):6488-93. 23576740 10.1073/pnas.1221312110 3631668
41. Vasconcelos Z Müller S Guipouy D: Individual Human Cytotoxic T Lymphocytes Exhibit Intraclonal Heterogeneity during Sustained Killing. Cell Rep. 2015;11(9):1474-85. 26027932 10.1016/j.celrep.2015.05.002
42. Bechara E Dijoud F de Saint Basile G: Hemophagocytic lymphohistiocytosis with Munc13-4 mutation: a cause of recurrent fatal hydrops fetalis. Pediatrics. 2011;128(1):e251-4. 21646258 10.1542/peds.2010-0764
43. Levendoglu-Tugal O Ozkaynak MF LaGamma E: Hemophagocytic lymphohistiocytosis presenting with thrombocytopenia in the newborn. J Pediatr Hematol Oncol. 2002;24(5):405-9. 12142793 10.1097/00043426-200206000-00017
44. Odermatt B Eppler M Leist TP: Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci U S A. 1991;88(18):8252-6. 1910175 10.1073/pnas.88.18.8252 52485
45. Terrell CE Jordan MB: Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8 + T cells and dendritic cells. Blood. 2013;121(26):5184-91. 23660960 10.1182/blood-2013-04-495309 3695362
46. Sepulveda FE Debeurme F Ménasché G: Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11. Blood. 2013;121(4):595-603. 23160464 10.1182/blood-2012-07-440339
47. Waggoner SN Cornberg M Selin LK: Natural killer cells act as rheostats modulating antiviral T cells. Nature. 2012;481(7381):394-8. 22101430 10.1038/nature10624 3539796
48. Lang PA Lang KS Xu HC: Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8 + T-cell immunity. Proc Natl Acad Sci U S A. 2012;109(4):1210-5. 22167808 10.1073/pnas.1118834109 3268324
49. Kögl T Müller J Jessen B: Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. Blood. 2013;121(4):604-13. 23190531 10.1182/blood-2012-07-441139
50. Faroudi M Utzny C Salio M: Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold. Proc Natl Acad Sci U S A. 2003;100(24):14145-50. 14610278 10.1073/pnas.2334336100 283560
51. Jenkins MR Rudd-Schmidt JA Lopez JA: Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212(3):307-17. 25732304 10.1084/jem.20140964 4354371
52. Strauss R Neureiter D Westenburger B: Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients--a postmortem clinicopathologic analysis. Crit Care Med. 2004;32(6):1316-21. 15187513 10.1097/01.CCM.0000127779.24232.15
53. Zoller EE Lykens JE Terrell CE: Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med. 2011;208(6):1203-14. 21624938 10.1084/jem.20102538 3173248
54. de Jesus AA Canna SW Liu Y: Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol. 2015;33:823-74. 25706096 10.1146/annurev-immunol-032414-112227 4563985
55. Krebs P Crozat K Popkin D: Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood. 2011;117(24):6582-8. 21551232 10.1182/blood-2011-01-329607 3123024
56. Milner JD Orekov T Ward JM: Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood. 2010;116(14):2476-83. 20570861 10.1182/blood-2009-11-255174 2953884
57. Behrens EM Canna SW Slade K: Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest. 2011;121(6):2264-77. 21576823 10.1172/JCI43157 3104738
58. Pachlopnik Schmid J Canioni D Moshous D: Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood. 2011;117(5):1522-9. 21119115 10.1182/blood-2010-07-298372
59. Nichols KE Harkin DP Levitz S: Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 1998;95(23):13765-70. 9811875 10.1073/pnas.95.23.13765 24894
60. Coffey AJ Brooksbank RA Brandau O: Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20(2):129-35. 9771704 10.1038/2424
61. Sayos J Wu C Morra M: The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998;395(6701):462-9. 9774102 10.1038/26683
62. Palendira U Low C Chan A: Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 2011;9(11):e1001187. 22069374 10.1371/journal.pbio.1001187 3206011
63. Tangye SG: XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. J Clin Immunol. 2014;34(7):772-9. 25085526 10.1007/s10875-014-0083-7
64. Rigaud S Fondanèche M Lambert N: XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444(7115):110-4. 17080092 10.1038/nature05257
65. Chung BK Tsai K Allan LL: Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood. 2013;122(15):2600-8. 23974196 10.1182/blood-2013-01-480665
66. Yabal M Müller N Adler H: XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 2014;7(6):1796-808. 24882010 10.1016/j.celrep.2014.05.008
67. Chia J Yeo KP Whisstock JC: Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proc Natl Acad Sci U S A. 2009;106(24):9809-14. 19487666 10.1073/pnas.0903815106 2701033
68. Nagafuji K Nonami A Kumano T: Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica. 2007;92(7):978-81. 17606450 10.3324/haematol.11233
69. Mancebo E Allende LM Guzmán M: Familial hemophagocytic lymphohistiocytosis in an adult patient homozygous for A91V in the perforin gene, with tuberculosis infection. Haematologica. 2006;91(9):1257-60. 16956828
70. Shabbir M Lucas J Lazarchick J: Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011;29(2):100-6. 20809477 10.1002/hon.960
71. Zhang M Behrens EM Atkinson TP: Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep. 2014;16(9):439. 25086802 10.1007/s11926-014-0439-2
72. Zhang K Jordan MB Marsh RA: Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118(22):5794-8. 21881043 10.1182/blood-2011-07-370148 3228496
73. Zhang K Chandrakasan S Chapman H: Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood. 2014;124(8):1331-4. 24916509 10.1182/blood-2014-05-573105 4141517
74. Romberg N Al Moussawi K Nelson-Williams C: Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet. 2014;46(10):1135-9. 25217960 10.1038/ng.3066 4177367
75. Canna SW de Jesus AA Gouni S: An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46(10):1140-6. 25217959 10.1038/ng.3089 4177369
76. Kitamura A Sasaki Y Abe T: An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med. 2014;211(12):2385-96. 25385754 10.1084/jem.20141091 4235634